1,125
Views
60
CrossRef citations to date
0
Altmetric
Reviews

Current status of inflammasome blockers as anti-inflammatory drugs

&
Pages 995-1007 | Published online: 22 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Sameh Saber, Galal Yahya, Naglaa A Gobba, Hossam Sharaf, Reem Alshaman, Abdullah Alattar, Noha A Amin, Ruwyda El-Shedody, Farah H Aboutouk, Yumna Abd El-Galeel, Amr El-Hefnawy, Dina Shabaka, Arwa Khalifa, Renad Saleh, Donya Osama, Ghada El-Zoghby & Mahmoud E Youssef. (2021) The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis. Journal of Inflammation Research 14, pages 3443-3463.
Read now
Ahmad Karkhah, Mahdiye Saadi, Fereshteh Pourabdolhossein, Kiarash Saleki & Hamid Reza Nouri. (2021) Indomethacin attenuates neuroinflammation and memory impairment in an STZ-induced model of Alzheimer’s like disease. Immunopharmacology and Immunotoxicology 43:6, pages 758-766.
Read now
Hamza Malik Okuyan & Mehmet A. Begen. (2021) miRNAs as attractive diagnostic and therapeutic targets for Familial Mediterranean Fever. Modern Rheumatology 31:5, pages 949-959.
Read now
Seyed Ahmad Rasoulinejad, Ahmad Karkhah, Alireza Paniri, Kiarash Saleki, Marzieh Pirzadeh & Hamid Reza Nouri. (2020) Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy. Immunopharmacology and Immunotoxicology 42:5, pages 400-407.
Read now
Mahdi Gouravani, Nastaran Khalili, Sepideh Razi, Mahsa Keshavarz-Fathi, Neda Khalili & Nima Rezaei. (2020) The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Review of Clinical Immunology 16:2, pages 175-187.
Read now
Vijay Kumar. (2018) Inflammasomes: Pandora’s box for sepsis. Journal of Inflammation Research 11, pages 477-502.
Read now

Articles from other publishers (54)

Hayley Barnes, Maggie Lam, Michelle D. Tate & Ryan Hoy. (2023) Toward targeted treatments for silicosis. Current Opinion in Pulmonary Medicine.
Crossref
Jesús M. Pérez-Gómez, Antonio J. Montero-Hidalgo, Antonio C. Fuentes-Fayos, André Sarmento-Cabral, Rocio Guzmán-Ruiz, María M. Malagón, Aura D. Herrera-Martínez, Manuel D. Gahete & Raúl M. Luque. (2023) Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity. Reviews in Endocrine and Metabolic Disorders 24:6, pages 1165-1187.
Crossref
Erika Ramos-Tovar & Pablo Muriel. (2023) NLRP3 inflammasome in hepatic diseases: A pharmacological target. Biochemical Pharmacology 217, pages 115861.
Crossref
Behram Khan Ghazi, Maria Hussain Bangash, Anam Abdul Razzaq, Madiha Kiyani, Shishay Girmay, Waleed Razzaq Chaudhary, Usman Zahid, Uzma Hussain, Huma Mujahid, Usama Parvaiz, Irfan Ahmed Buzdar, Shah Nawaz & Mohamed Farouk Elsadek. (2023) In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases. BioMed Research International 2023, pages 1-16.
Crossref
Callum AH Docherty, Anuruddika J Fernando, Sarah Rosli, Maggie Lam, Roland E Dolle, Manuel A Navia, Ronald Farquhar, Danny La France, Michelle D Tate, Christopher K Murphy, Adriano G Rossi & Ashley Mansell. (2023) A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases . Clinical & Translational Immunology 12:6.
Crossref
Long Guo, Zhihao Wang, Jun Li, Luying Cui, Junsheng Dong, Xia Meng, Guoqiang Zhu, Jianji Li & Heng Wang. (2022) MCC950 attenuates inflammation-mediated damage in canines with Staphylococcus pseudintermedius keratitis by inhibiting the NLRP3 inflammasome. International Immunopharmacology 108, pages 108857.
Crossref
Pablo Muriel. 2022. Hepatic Fibrosis. Hepatic Fibrosis 25 53 .
Avik Shome, Odunayo O. Mugisho, Rachael L. Niederer & Ilva D. Rupenthal. (2021) Blocking the inflammasome: A novel approach to treat uveitis. Drug Discovery Today 26:12, pages 2839-2857.
Crossref
Gholamreza Bahari, Farhad Tabasi, Mohammad Hashemi, Zahra Zakeri & Mohsen Taheri. (2021) Association of P2X7 receptor genetic polymorphisms and expression with rheumatoid arthritis susceptibility in a sample of the Iranian population: a case-control study. Clinical Rheumatology 40:8, pages 3115-3126.
Crossref
Pablo Pelegrin. (2021) P2X7 receptor and the NLRP3 inflammasome: Partners in crime. Biochemical Pharmacology 187, pages 114385.
Crossref
Danwen Wang, Hui Wang, Haixia Gao, Heng Zhang, Hua Zhang, Qiuling Wang & Zhiling Sun. (2020) P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes. Cell & Bioscience 10:1.
Crossref
Hari Prasad, Avinash Ravindranath Shenoy & Sandhya Srikant Visweswariah. (2020) Cyclic nucleotides, gut physiology and inflammation. The FEBS Journal 287:10, pages 1970-1981.
Crossref
Kenan Yalta, Mehmet Birhan Yilmaz, Tulin Yalta, Orkide Palabiyik, Gokay Taylan & Cafer Zorkun. (2019) Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications. Journal of Cardiovascular Pharmacology and Therapeutics 25:1, pages 15-26.
Crossref
Jiangyuan Gao, Jing Z. Cui, Aikun Wang, Hao Hang Rachel Chen, Alison Fong & Joanne A. Matsubara. (2019) The reduction of XIAP is associated with inflammasome activation in RPE: implications for AMD pathogenesis. Journal of Neuroinflammation 16:1.
Crossref
Lili Yu, Yanhua Li, Cancan Du, Weidong Zhao, Hanxiao Zhang, Yun Yang, Aiping Sun, Xiangfeng Song & Zhiwei Feng. (2019) Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases. Mediators of Inflammation 2019, pages 1-14.
Crossref
Álvaro Sebastián-Serrano, Laura de Diego-García, Caterina di Lauro, Carolina Bianchi & Miguel Díaz-Hernández. (2019) Nucleotides regulate the common molecular mechanisms that underlie neurodegenerative diseases; Therapeutic implications. Brain Research Bulletin 151, pages 84-91.
Crossref
Cristina Alarcón-Vila, Malvina Pizzuto & Pablo Pelegrín. (2019) Purinergic receptors and the inflammatory response mediated by lipids. Current Opinion in Pharmacology 47, pages 90-96.
Crossref
Kurt T. K. Giuliani, Andrew J. Kassianos, Helen Healy & Pedro H. F. Gois. (2019) Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis. International Journal of Molecular Sciences 20:8, pages 1997.
Crossref
Penghui Wei, Fan Yang, Qiang Zheng, Wenxi Tang & Jianjun Li. (2019) The Potential Role of the NLRP3 Inflammasome Activation as a Link Between Mitochondria ROS Generation and Neuroinflammation in Postoperative Cognitive Dysfunction. Frontiers in Cellular Neuroscience 13.
Crossref
Faith L Anderson, Madeleine M Coffey, Brent L Berwin & Matthew C Havrda. (2018) Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson’s Disease. Toxicological Sciences 166:1, pages 3-15.
Crossref
Perrine Bortolotti, Emmanuel Faure & Eric Kipnis. (2018) Inflammasomes in Tissue Damages and Immune Disorders After Trauma. Frontiers in Immunology 9.
Crossref
Honglei RenYing KongZhijia LiuDongyun ZangXiaoxia YangKristofer WoodMinshu LiQiang Liu. (2018) Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage. Stroke 49:1, pages 184-192.
Crossref
Wen-Jun Su, Wei Peng, Hong Gong, Yun-Zi Liu, Yi Zhang, Yong-Jie Lian, Zhi-Yong Cao, Ran Wu, Lin-Lin Liu, Bo Wang, Yun-Xia Wang & Chun-Lei Jiang. (2017) Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. Journal of Neuroinflammation 14:1.
Crossref
Maria Barberà-Cremades, Ana I. Gómez, Alberto Baroja-Mazo, Laura Martínez-Alarcón, Carlos M. Martínez, Carlos de Torre-Minguela & Pablo Pelegrín. (2017) P2X7 Receptor Induces Tumor Necrosis Factor-α Converting Enzyme Activation and Release to Boost TNF-α Production. Frontiers in Immunology 8.
Crossref
Huyen Trang Ha Thi & Suntaek Hong. (2017) Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment. Journal of Cancer Prevention 22:2, pages 62-73.
Crossref
Mattia Cocco, Carolina PellegriniHelios Martínez-Banaclocha, Marta Giorgis, Elisabetta Marini, Annalisa Costale, Gianluca Miglio, Matteo Fornai, Luca Antonioli, Gloria López-CastejónAna Tapia-Abellán, Diego Angosto, Iva Hafner-Bratkovič, Luca Regazzoni, Corrado Blandizzi, Pablo Pelegrín & Massimo Bertinaria. (2017) Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry 60:9, pages 3656-3671.
Crossref
Olga V. Oskolkova, Viktoria Godschachner & Valery N. Bochkov. (2017) Off-Target Anti-Inflammatory Activity of the P2X7 Receptor Antagonist AZ11645373. Inflammation 40:2, pages 530-536.
Crossref
Carlos de Torre-Minguela, Pablo Mesa del Castillo & Pablo Pelegrín. (2017) The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases. Frontiers in Immunology 8.
Crossref
Carolina Pellegrini, Luca Antonioli, Gloria Lopez-Castejon, Corrado Blandizzi & Matteo Fornai. (2017) Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. Frontiers in Immunology 8.
Crossref
Francisco M. Nadal-Nicolás, Caridad Galindo-Romero, Francisco J. Valiente-Soriano, María Barberà-Cremades, Carlos deTorre-Minguela, Manuel Salinas-Navarro, Pablo Pelegrín & Marta Agudo-Barriuso. (2016) Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury. Scientific Reports 6:1.
Crossref
Patrick Dutartre. (2016) Inflammasomes and Natural Ingredients towards New Anti-Inflammatory Agents. Molecules 21:11, pages 1492.
Crossref
Ryan Kolb, Liem Phan, Nicholas Borcherding, Yinghong Liu, Fang Yuan, Ann M. Janowski, Qing Xie, Kathleen R. Markan, Wei Li, Matthew J. Potthoff, Enrique Fuentes-Mattei, Lesley G. Ellies, C. Michael Knudson, Mong-Hong Lee, Sai-Ching J. Yeung, Suzanne L. Cassel, Fayyaz S. Sutterwala & Weizhou Zhang. (2016) Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nature Communications 7:1.
Crossref
Alvin Lu, Yang Li, Florian I Schmidt, Qian Yin, Shuobing Chen, Tian-Min Fu, Alexander B Tong, Hidde L Ploegh, Youdong Mao & Hao Wu. (2016) Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism. Nature Structural & Molecular Biology 23:5, pages 416-425.
Crossref
Nidhi Sharma & Sushmita Jha. (2015) NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions. Cellular and Molecular Life Sciences 73:9, pages 1741-1764.
Crossref
HAMID REZA NOURI, AHMAD KARKHAH, IRAJ MOHAMMADZADEH & MOJTABA SANKIAN. (2016) Elevated caspase-1 activity and IL-1β expression are associated with the IPAF inflammasome in an experimental model of allergy. Molecular Medicine Reports 13:4, pages 3356-3362.
Crossref
Geoffrey Burnstock. (2016) P2X ion channel receptors and inflammation. Purinergic Signalling 12:1, pages 59-67.
Crossref
Linna Wang, Jiwei Ma, Cunxia Guo, Changyong Chen, Zhong Yin, Xueguang Zhang & Xiangmei Chen. (2016) Danggui Buxue Tang Attenuates Tubulointerstitial Fibrosis via Suppressing NLRP3 Inflammasome in a Rat Model of Unilateral Ureteral Obstruction. BioMed Research International 2016, pages 1-12.
Crossref
Amma Owusu-Ansah, Chibueze A. Ihunnah, Aisha L. Walker & Solomon F. Ofori-Acquah. (2016) Inflammatory targets of therapy in sickle cell disease. Translational Research 167:1, pages 281-297.
Crossref
Shui-Xing Yu, Chong-Tao Du, Wei Chen, Qian-Qian Lei, Ning Li, Shuai Qi, Xiao-Jing Zhang, Gui-Qiu Hu, Xu-Ming Deng, Wen-Yu Han & Yong-Jun Yang. (2015) Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression. Scientific Reports 5:1.
Crossref
Ya-Ping Chang, Shuk-Man Ka, Wan-Han Hsu, Ann Chen, Louis Kuoping Chao, Chai-Ching Lin, Cho-Chen Hsieh, Ming-Cheng Chen, Huan-Wen Chiu, Chen-Lung Ho, Yi-Chich Chiu, May-Lan Liu & Kuo-Feng Hua. (2015) Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy. Journal of Cellular Physiology 230:7, pages 1567-1579.
Crossref
Y. Zhang, L. Liu, Y.-Z. Liu, X.-L. Shen, T.-Y. Wu, T. Zhang, W. Wang, Y.-X. Wang & C.-L. Jiang. (2015) NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation. International Journal of Neuropsychopharmacology 18:8, pages pyv006-pyv006.
Crossref
Yanli Yan, Jianwen BaiXiaoxu Zhou, Jinhua Tang, Chunming Jiang, Evelyn Tolbert, George Bayliss, Rujun Gong, Ting C. Zhao & Shougang Zhuang. (2015) P2X7 receptor inhibition protects against ischemic acute kidney injury in mice. American Journal of Physiology-Cell Physiology 308:6, pages C463-C472.
Crossref
Jiangyuan Gao, Ruozhou Tom Liu, Sijia Cao, Jing Z. Cui, Aikun Wang, Eleanor To & Joanne A. Matsubara. (2015) NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration. Mediators of Inflammation 2015, pages 1-11.
Crossref
Mattia Cocco, Davide Garella, Antonella Di Stilo, Emily Borretto, Livio Stevanato, Marta Giorgis, Elisabetta Marini, Roberto Fantozzi, Gianluca Miglio & Massimo Bertinaria. (2014) Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis. Journal of Medicinal Chemistry 57:24, pages 10366-10382.
Crossref
Mònica Aguilera, Trevor Darby & Silvia Melgar. (2014) The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases – Lessons learned from experimental models. Cytokine & Growth Factor Reviews 25:6, pages 715-730.
Crossref
Antero Salminen, Anu Kauppinen, Mikko Hiltunen & Kai Kaarniranta. (2013) Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function. Cellular and Molecular Life Sciences 71:10, pages 1855-1864.
Crossref
Carlo Marchetti, Jeremy Chojnacki, Stefano Toldo, Eleonora Mezzaroma, Nicla Tranchida, Scott W. Rose, Massimo Federici, Benjamin W. Van Tassell, Shijun Zhang & Antonio Abbate. (2014) A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse. Journal of Cardiovascular Pharmacology 63:4, pages 316-322.
Crossref
Nolan K. Maier, Devorah Crown, Jie Liu, Stephen H. Leppla & Mahtab Moayeri. (2014) Arsenic Trioxide and Other Arsenical Compounds Inhibit the NLRP1, NLRP3, and NAIP5/NLRC4 Inflammasomes. The Journal of Immunology 192:2, pages 763-770.
Crossref
Yuan He, Saranyaraajan Varadarajan, Raúl Muñoz-Planillo, Aaron Burberry, Yuumi Nakamura & Gabriel Núñez. (2014) 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome. Journal of Biological Chemistry 289:2, pages 1142-1150.
Crossref
Justin A. MacDonald, Champa P. Wijekoon, Kuo-Chieh Liao & Daniel A. Muruve. (2013) Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins. IUBMB Life 65:10, pages 851-862.
Crossref
Francesco Di Virgilio. (2013) The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors. Pharmacological Reviews 65:3, pages 872-905.
Crossref
Moritz Haneklaus, Luke AJ O’Neill & Rebecca C Coll. (2013) Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Current Opinion in Immunology 25:1, pages 40-45.
Crossref
Gloria Lopez-Castejon, Nadia M. Luheshi, Vincent Compan, Stephen High, Roger C. Whitehead, Sabine Flitsch, Aleksandr Kirov, Igor Prudovsky, Eileithyia Swanton & David Brough. (2013) Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome. Journal of Biological Chemistry 288:4, pages 2721-2733.
Crossref
Bénédicte F. Py, Mi-Sung Kim, Helin Vakifahmetoglu-Norberg & Junying Yuan. (2013) Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity. Molecular Cell 49:2, pages 331-338.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.